Abbott Laboratories/ US0028241000 /
| 06/11/2024 10:57:17 | Chg. +7.58 | Volume | Bid17:29:18 | Ask17:29:18 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 112.46EUR | +7.23% | 104 Turnover: 11,695.84 |
-Bid Size: - | -Ask Size: - | 185.43 bill.EUR | - | - |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 8,038 | 9,029 | 8,959 | 9,162 | 10,154 | ||||||
| Intangible Assets | 17,025 | 14,784 | 12,739 | 10,454 | 8,815 | ||||||
| Long-Term Investments | 883 | 821 | 816 | 766 | 799 | ||||||
| Fixed Assets | 52,220 | 52,107 | 50,957 | 49,214 | 50,544 | ||||||
| Inventories | 4,316 | 5,012 | 5,157 | 6,173 | 6,570 | ||||||
| Accounts Receivable | 5,425 | 6,414 | 6,487 | 6,218 | 6,565 | ||||||
| Cash and Cash Equivalents | 3,860 | 6,838 | 9,799 | 9,882 | 6,896 | ||||||
| Current Assets | 15,667 | 20,441 | 24,239 | 25,224 | 22,670 | ||||||
| Total Assets | 67,887 | 72,548 | 75,196 | 74,438 | 73,214 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 3,252 | 3,946 | 4,408 | 4,607 | 4,295 | ||||||
| Long-term debt | 16,661 | 18,527 | 17,296 | 14,522 | 13,599 | ||||||
| Liabilities to Banks | 201 | 213 | 0.0000 | - | - | ||||||
| Provisions | 226 | 362 | 306 | - | - | ||||||
| Liabilities | 36,586 | 39,545 | 39,172 | 37,533 | 34,387 | ||||||
| Share Capital | 23,853 | 24,145 | 24,470 | 24,709 | 24,869 | ||||||
| Total Equity | 31,301 | 33,003 | 36,024 | 36,905 | 38,827 | ||||||
| Minority Interests | 213 | 219 | 222 | 219 | 224 | ||||||
| Total liabilities equity | 67,887 | 72,548 | 75,196 | 74,438 | 73,214 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 31,904 | 34,608 | 43,075 | 43,653 | 40,109 | ||||||
| Depreciation (total) | 3,014 | 3,327 | 3,538 | 3,267 | 3,243 | ||||||
| Operating Result | 4,532 | 5,357 | 8,425 | 8,362 | 6,478 | ||||||
| Interest Income | -576 | -500 | -490 | -375 | -252 | ||||||
| Income Before Taxes | 4,077 | 4,968 | 8,211 | 8,306 | 6,664 | ||||||
| Income Taxes | 390 | 497 | 1,140 | 1,373 | 941 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 3,687 | 4,495 | 7,071 | 6,933 | 5,723 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 6,136 | 7,901 | 10,533 | 9,581 | 7,261 | ||||||
| Cash Flow from Investing Activities | -1,815 | -2,215 | -2,008 | -1,740 | -3,133 | ||||||
| Cash Flow from Financing | -4,289 | -2,779 | -5,494 | -7,636 | -7,091 | ||||||
| Decrease / Increase in Cash | 16 | 2,978 | 2,961 | 83 | -2,986 | ||||||
| Employees | 107,000 | 109,000 | 113,000 | - | - | ||||||
